Société Opexa Therapeutics Inc Nasdaq
Actions
US68372T2024
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Tanya Hayden
COO | Chief Operating Officer | 44 | 01/06/21 |
John M. Klopp
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Jim DeNike
IRC | Investor Relations Contact | - | - |
Bernie Paul
HRO | Human Resources Officer | 65 | 01/05/19 |
Renee Carroll
LAW | General Counsel | - | 01/01/20 |
Jason Kneeland
AUD | Comptroller/Controller/Auditor | - | 01/11/17 |
Kim Tharaldsen
SAM | Sales & Marketing | - | 05/02/18 |
Corporate Officer/Principal | 57 | 01/12/13 | |
Donald Joseph
LAW | General Counsel | 70 | 01/04/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Joshua Schafer
BRD | Director/Board Member | 53 | 17/11 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 24 463 726 | 24 463 726 ( 100,00 %) | 0 | 100,00 % |
Coordonnées société
![Adresse Opexa Therapeutics Inc](https://cdn.zonebourse.com/static/address/12191752.png)
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+15,58% | 121 Md | |
+16,60% | 110 Md | |
+18,78% | 25,93 Md | |
-24,33% | 19,27 Md | |
-19,51% | 16,01 Md | |
-17,95% | 15,66 Md | |
-46,81% | 14,89 Md | |
+58,78% | 14,47 Md | |
+4,91% | 13,91 Md |